Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Workday Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Workday Inc trades at $188.12 (market cap $44.83B). The key difference: Workday Inc is far larger — about 5.3× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Workday Inc for 38 Days on average.
| HNGE | WDAY | |
|---|---|---|
Market Cap | $8.48B | $44.83B |
Volume | 879,799 | 2,168,736 |
Sector | Health | Technology |
52-Week High | $105.14 | $245.67 |
52-Week Low | $31.17 | $112.55 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $8.10B | $45.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Workday (WDAY) trades at $188.77, up 0.28% today, with a bullish technical signal from moving averages and a consensus analyst price target of $203.19. The company has beaten earnings estimates for the last three quarters, with Q3 2026 EPS expected at $2.74. Revenue grew to $8.45 billion in 2025, and recent news highlights AI product launches and strategic partnerships, though layoffs and a fraud investigation present headwinds.
WDAY offers growth potential driven by AI integration and expanding market presence, but faces risks from competitive pressures and execution challenges. The stock's valuation multiples are elevated, requiring sustained earnings growth to justify current levels. Investor sentiment is mixed amid operational adjustments and legal scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
